Rhetoric, Professional Communication, and Medical Controversy Heidi

Total Page:16

File Type:pdf, Size:1020Kb

Rhetoric, Professional Communication, and Medical Controversy Heidi Conscientious Object-ion: Rhetoric, Professional Communication, and Medical Controversy Heidi Yoston Lawrence Dissertation submitted to the faculty of the Virginia Polytechnic Institute and State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy In Rhetoric and Writing Bernice L. Hausman Paul V. Heilker Kelly E. Pender Carolyn D. Rude April 25, 2013 Blacksburg, Virginia Keywords: vaccination, medical rhetoric, professional communication Copyright © 2013 Heidi Y. Lawrence Conscientious Object-ion: Rhetoric, Professional Communication, and Medical Controversy Heidi Yoston Lawrence ABSTRACT Vaccination is power—power to prevent disease, power to shape populations, power to define sickness and health, and power to compel scientific beliefs into the bodies of people around the globe. It is unsurprising, therefore, that vaccinations have garnered centuries of dissent. Specifically, the conscience—the parent or patient’s perceived right to make vaccination decisions based on personal perceptions of acceptable risks—has been used since vaccination’s inception as a rationale for individual rights to refuse vaccines in the face of the very public health goals that vaccinations aim to achieve. Existing studies of vaccine disputes in medical literature have understood vaccine questions to be a problem of scientific knowledge or literacy, claiming largely that vaccine skepticism arises from a lack of proper comprehension or understanding of the scientific and medical bases for vaccination or statistical evidence proving vaccines are safe and effective. Studies of vaccination controversy in social science, communications, and historical literatures have largely examined the role that alternative notions of risk valuation, sources of trusted health information (such as preferring the advice of friends and neighbors to doctors), or conceptions of uncertainty have played in largely parental decision making about childhood vaccinations. Despite these extensive studies of vaccine sentiment, vaccine skepticism and refusal remains a small, though significant, voice in public debate. This dissertation examines vaccine discourses as object-oriented rhetorics—as rhetorics shaped and defined by the physicality of the vaccine’s operation—as a way of re-conceptualizing the vaccine debate. Using object-oriented theories from computer programming, philosophy, and rhetoric, this research examines the professional and public voices that make up contemporary vaccine controversy. Through three data sets, including interviews with physicians, parent discourses produced on the Internet, and survey responses from young adults, this dissertation observes that vaccines function as objects that have multiple, coexisting operations for different actors across the medical system. Consequently, vaccination controversy can be conceptualized not as accurate versus inaccurate understandings of science or as a conflict of perspectives, but instead as a by-product of multiple ontologies of vaccines at work under competing disease exigencies. ! Dedication I dedicate this dissertation to my friends and family, without whom I never could have completed this work. To all of the bosses, mentors, and co-workers who have shaped and inspired my professional, intellectual, and personal lives, especially: Steve George, Steve Lowery, Dr. Byron Hawk, Dr. Eric Anderson, Kimberly Bibbee, and Gregg Nugent. Your leadership, support, advice, and counsel at key moments in my career have made every subsequent step I have taken possible. To my dearest friends, Kellie Bryan, Shelley Groves Rakip, Kimberly Hall, and Abby Waldron. Your long conversations, timely emails, and much-needed laughter have brought joy and comfort at key moments throughout my PhD program and entire career. I am inspired by you all and the lives, careers, and families you have built. To the amazing members of my PhD cohort at Virginia Tech, Dr. Libby Anthony, Dr. Kerry Dirk, Dr. Scott Kowalewski, Dr. Molly Scanlon, and Dr. Matt Sharp. I am proud to leave Tech alongside such talented colleagues, all of whom I am also glad to call friends. Kind of like honey love on your computer. To my friend and colleague, Dr. Libby Anthony. I never could have done this without your support, camaraderie, and, most of all, humor. I will always be grateful for the times we shared during this often-arduous process—in our offices, in coffee shops, in the library, and in the rolling hills and hollers of Southwest Virginia—toiling away at writing, research, or whatever task was demanded of us, all while hysterically laughing at it all. We have endured so much together, and I’m forever thankful for your friendship. To my sisters, Aubree and Hannah Lawrence. Although most people love their siblings, not everyone is fortunate enough to like them as much as I genuinely like you both. Although we are all so different and have lived very different parts of our lives together, I love that we can share—in alternating moments—a mutual love of books, coffee, How I Met Your Mother, language, kittens, wine, politics, and The Real Housewives. Thank you both for being such amazing sisters and friends. To my parents, Richard and Dorothy Lawrence. Thank you for the high standards you always set for our whole family—from an early age, there was never such a thing as getting up too early, staying up too late, or working too hard to meet the goals we set for ourselves. You both always led by example, holding yourselves to incredibly high standards as parents and professionals, showing your three daughters that anything was possible with enough hard work. These values have made everything I’ve attained possible. I am so proud to be your daughter. To Ryan. My companion and partner, my life. With you, life has been limitless, only bound by what we’ve been able to imagine for ourselves. You have taught me that, in pursuing our dreams, we will gain more than we could have ever expected, sacrifice more than we thought we could give, endure even the most heart-wrenching loss, and love more deeply than we knew we could love. Thank you for everything you have done to make my life as full as it is. I love you. iii Acknowledgements I would like to thank everyone who made the work of this dissertation possible. I thank all of my research participants, particularly the eight doctors who consented to be interviewed for the research presented in Chapter 4. Their candor and insight into vaccines and the roles they play in the practice of medicine informed and inspired not only that chapter but the larger theoretical frame and arguments this research aims to make. I thank past members of the Vaccination Research Group (VRG) at Virginia Tech for their research, insights, and diligent work, including: Megan Casady, Jonathan Chapman, Lauren Cobert, Erica Frempong, Jessica Fuller, Leanne Shelley, Carly Smith, Kelsey Soppet, Aubrey Sozer, Josh Trebach, and Andria Wallen. In particular, I thank Rachel Dinkins, Olivia Kasik, Dasha Nesterova, and Karen Spears. Their hard work made much of this research possible, particularly the physicians’ interviews and flu survey. They have indelibly shaped this research, and I feel incredibly fortunate to have learned so much from them. I thank the faculty in Virginia Tech’s Rhetoric and Writing program for their insight, generosity, and support throughout my graduate study, particularly Dr. Clare Dannenberg, Dr. Carlos Evia, Dr. Diana George, and Dr. Katy Powell. I thank Dr. Dannenberg and Dr. Powell, in particular, for their mentorship in research and professional assistance throughout my time at Tech. My work has been forever shaped by their perspectives on research methods and how they determine the way we ask questions and gain answers when addressing issues of Rhetoric in Society. I’m also so thankful for their candor, their support, and mostly, their humor. I thank my dissertation committee members, Dr. Paul Heilker, Dr. Kelly Pender, and Dr. Carolyn Rude. I have been honored by their participation on my committee and their contributions to this project. Dr. Heilker’s unwavering confidence in me has inspired my work in ways words fail to describe. I thank him, so much, for his constant faith in me as a student and scholar. Dr. Pender’s smart sensibility and unwavering ethics as a teacher, researcher, and rhetorician are all qualities to which I aspire. I have learned so very much from her and thank her for never hesitating to ask the tough questions. Dr. Rude’s commitment to the study, practice, and teaching of professional communication will forever inspire my work, and I remain amazed by the ways she drives the field—and herself—into new pedagogical and political terrain. I thank her for shaping my career in such lasting, significant ways. My most sincere thanks go to my dissertation director, Dr. Bernice Hausman. From the moment I began working with her, I knew that she would push me to learn and be and accomplish things far beyond what I could imagine for myself. At every turn, she has never disappointed. From coursework, to my work with the VRG, through exams, and now with this dissertation, Dr. Hausman has influenced my work in countless ways, sometimes pushing back, sometimes getting out of my way, always guiding with necessary questions and critique. She introduced me to this topic, encouraged me to pursue it for my dissertation research, and provided extensive support in both time and resources, all of which truly made this work possible. Through all of this, she has also been an amazing example—as a person, as a teacher, as a scholar. I thank her for everything, particularly for all of the confidence she has had in me, always. iv Table of Contents TABLE OF CONTENTS V LIST OF FIGURES VII LIST OF TABLES VIII LIST OF ABBREVIATIONS IX INTRODUCTION. “I HAVE A CONSCIENTIOUS OBJECTION TO CHILD MURDER”: OBJECTS, RHETORICS, AND VACCINE CONTROVERSY 1 STANDARD HISTORY OF VACCINATION AND VACCINE CONTROVERSY 5 VACCINE CONTROVERSY TODAY 10 VACCINES AND DELIVERY MECHANISMS 14 ON VACCINE REQUIREMENTS 15 OBJECT-ORIENTED RHETORICS AND VACCINE ONTOLOGY 20 CHAPTER 1.
Recommended publications
  • Crisis Communication
    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School 6-20-2014 Crisis Communication: Sensemaking and Decision-making by the CDC Under Conditions of Uncertainty and Ambiguity During the 2009-2010 H1N1 Pandemic Barbara Bennington University of South Florida, [email protected] Follow this and additional works at: https://scholarcommons.usf.edu/etd Part of the Communication Commons Scholar Commons Citation Bennington, Barbara, "Crisis Communication: Sensemaking and Decision-making by the CDC Under Conditions of Uncertainty and Ambiguity During the 2009-2010 H1N1 Pandemic" (2014). Graduate Theses and Dissertations. https://scholarcommons.usf.edu/etd/5181 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Crisis Communication: Sensemaking and Decision-Making by the CDC Under Conditions of Uncertainty and Ambiguity During the 2009-2010 H1N1 Pandemic by Barbara Bennington A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Communication College of Arts and Sciences University of South Florida Major Professor: Eric M. Eisenberg, Ph.D. Ambar Basu, Ph.D. Kenneth N. Cissna, Ph.D Stephen Turner, Ph.D Date of Approval: June 20th, 2014 Keywords: sensemaking, crisis communication, uncertainty, CDC, H1N1 Copyright ©2014, Barbara Bennington ACKNOWLEDGMENTS My first thank-you goes to Dr. Marsha Vanderford who had the idea to develop an oral history of the CDC’s response to H1N1 and who offered me the opportunity to participate in the project.
    [Show full text]
  • Swine Influenza a (H1N1 Virus): a Pandemic Disease
    Review Article Swine Influenza A (H1N1 Virus): A Pandemic Disease Gangurde HH, Gulecha VS, Borkar VS, Mahajan MS, Khandare RA, Mundada AS Department of Pharmaceutics, SNJB’s SSDJ College of Pharmacy, Neminagar, Chandwad, Nasik, Maharashtra, India ARTICLE INFO ABSTRACT Article history: Swine influenza (SI) is a respiratory disease of pigs caused by type A influenza that regularly Received 9 September 2009 causes pandemics. SI viruses do not normally infect humans; however, human infections with Accepted 18 September 2009 SI do occur, and cases of human-to-human spread of swine flu viruses have been documented. Available online 19 October 2011 Swine influenza also called as swine flu, hog flu, and pig flu that refers to influenza is caused by Keywords: those strains of influenza virus, called SI virus (SIV), that usually infect pigs endemically. As of Coughing 2009, these strains are all found in influenza C virus and subtypes of influenza A virus known as Fever H1N1, H1N2, H3N1, H3N2, and H2N3. The viruses are 80–120 nm in diameter. The transmission of H1N1 SIV from pigs to humans is not common and does not always cause human influenza, often only sore throat resulting in the production of antibodies in the blood. The meat of the animal poses no risk of swine flu swine influenza virus transmitting the virus when properly cooked. If the transmission does cause human influenza, it is called zoonotic swine flu. People who work with pigs, especially people with intense exposures, are at an increased risk of catching swine flu. In the mid-20th century, the identification of influenza subtypes became possible; this allowed accurate diagnosis of transmission to humans.
    [Show full text]
  • Report on Narratives and Urban Myths
    D1.5 Report on Narratives and Urban Myths 1st Reporting period WP1 Population Behaviour during epidemics Responsible Partner: CSSC Contributing partners: Due date of the deliverable: M6 (July 31st 2012) Actual submission date: M9 (1st October 2012) Dissemination level: PU TELL ME ‐ Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence. Project co‐funded by the European Commission within the 7th Framework Programme – HEALTH theme D1.5 Report on Narratives and Urban Myths TELL ME project – GA: 278723 Table of Contents EXECUTIVE SUMMARY ................................................................................................................................................................ 4 1. Introduction ................................................................................................................................................................................. 6 2. The journey from myth to the urban myth ..................................................................................................................... 7 2.1 Portrait of the myth ............................................................................................................................................................. 7 2.2 The notion of disease in myth and tradition ............................................................................................................... 9 2.3 From myth to legend: Transcendent realities vs. falsified truths (?) ..............................................................
    [Show full text]
  • H1N1/09 Influenza: 20 Th Century Flu Pandemics
    Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research __________________________________________________ J. Chem. Pharm. Res., 2010, 2(3):605-619 ISSN No: 0975-7384 CODEN(USA): JCPRC5 H1N1/09 Influenza: 20 th Century flu pandemics Ravi Patel, Ishan Panchal, Dilip Chavda, Priya Modiya, Hiren Marvaniya, Kaumil Modi and Dhrubo Jyoti Sen Department of Pharmaceutical Chemistry, Shri Sarvajanik Pharmacy College, Gujarat Technological University, Mehsana, Gujarat ______________________________________________________________________________ ABSTRACT Swine influenza (also called Pig influenza, swine flu, hog flu and pig flu) is an infection by any one of several types of swine influenza virus. Swine influenza virus (SIV) or S-OIV (swine-origin influenza virus) is any strain of the influenza family of viruses that is endemic in pigs. As of 2009, the known SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H3N1, H3N2, and H2N3. Swine influenza virus is common throughout pig populations worldwide. Transmission of the virus from pigs to humans is not common and does not always lead to human influenza, often resulting only in the production of antibodies in the blood. If transmission does cause human influenza, it is called zoonotic swine flu. People with regular exposure to pigs are at increased risk of swine flu infection. The meat of infected animal posses no risk of infection when properly cooked. ______________________________________________________________________________ INTRODUCTION The 2009 flu pandemic is a global outbreak of a new strain of H1N1 influenza virus, often referred to as "swine flu" in the media. Although the virus, first detected in April 2009, contains a combination of genes from swine, avian (bird), and human influenza viruses, it cannot be spread by eating pork products or being around pigs.
    [Show full text]
  • The 2009 A(H1N1) Pandemic in Europe
    SPECIAL REPORT The 2009 A(H1N1) pandemic in Europe A review of the experience www.ecdc.europa.eu ECDC SPECIAL REPORT The 2009 A(H1N1) pandemic in Europe A review of the experience Authors: Amato Gauci AJ, Zucs P, Snacken R, Ciancio B, Lopez V, Broberg E, Penttinen P, Plata F, Nicoll A, on behalf of the EISN: Gabriela El Belazi, Hubert Hrabcik, Peter Lachner, Reinhild Strauss, Robert Muchl, Theresia Popow – Kraupp, Monika Redlberger-Fritz, Françoise Wuillaume, Françoise Wuillaume, Viviane Van Casteren, Isabelle Thomas, Bernard Brochier , Mira Kojouharova, Rositsa Kotseva, Teodora Georgieva, Avraam Elia, Chryso Gregoriadou, Chrystalla Hadjianastassiou, Despo Pieridou Bagatzouni, Olga Kalakouta, Jan Kyncl, Martina Havlickova, Andreas Gilsdorf, Brunhilde Schweiger, Gabriele Poggensee, Gerard Krause, Silke Buda, Tim Eckmanns, Anne Mazick, Annette Hartvig Christiansen, Kåre Mølbak, Lars Nielsen, Steffen Glismann, Inna Sarv, Irina Dontsenko, Jelena Hololejenko, Natalja Njunkova, Natalia Kerbo, Olga Sadikova, Tiiu Aro, Amparo Larrauri, Gloria Hernandez – Pezzi, Pilar Perez – Brena, Rosa Cano – Portero, Markku Kuusi, Petri Ruutu, Thedi Ziegler, Sophie Vaux, Isabelle Bonmarin, Daniel Lévy-Bruhl, Bruno Lina, Martine Valette, Sylvie Van Der Werf, Vincent Enouf, Ian Fisher, John Watson, Joy Kean, Maria Zambon, Mike Catchpole, Peter Coyle, William F Carman, Stefanos Bonovas, Takis Panagiotopoulos, Sotirios Tsiodras Ágnes Csohán, Istvan Jankovics, Katalin Kaszas, Márta Melles, Monika Rozsa, Zsuzsanna Molnár, Darina O'flanagan, Derval Igoe, Joan O’donnell, John Brazil, Margaret Fitzgerald, Peter Hanrahan, Sarah Jackson, Suzie Coughlan, Jeff Connell, Margaret Duffy, Joanne Moran, Professor William Hall, Arthur Löve, Gudrun Sigmundsdottir, Simona Puzelli, Isabella Donatelli, Maria Grazia Pompa, Stefania D'amato, Stefania Iannazzo, Annapina Palmieri, Sabine Erne, Algirdas Griskevicius, Nerija Kupreviciene, Rasa Liausediene, Danielle Hansen – Koenig, Joel Mossong, Mathias Opp, Claude P.
    [Show full text]
  • L'accélération Des Vaccinations Contre La Grippe Porcine Est À L'ordre Du Jour
    Santé Grippe "porcine" A [H1N1] L’accélération des vaccinations contre la grippe porcine est à l’ordre du jour Les vaccins sont bien plus meurtriers que la grippe porcine ; la vaccination de masse est une recette qui peut conduire à un désastre. Par le Dr. Mae-Wan Ho et le Professeur Joe Cummins Rapport de l’ ISIS en date du 27/07/2009 Ce rapport a été soumis à Sir Liam Donaldson, Chief Medical Officer [Directeur général de la santé] du Royaume-Uni, et à la US Food and Drugs Administration [ Administration américaine des denrées alimentaires et des médicaments des Etats- Unis]. S'il vous plaît, diffusez largement ce document, avec tous les liens inclus, à tous vos représentants élus, où que vous soyez Titre de cet article en anglais Fast - tracked Swine Flu Vaccine under Fire ; il est accessible sur le site de l’ISIS : www.i-sis.org.uk/fastTrackSwineFluVaccineUnderFire.php Une épidémie de grippe porcine s'est produite au Mexique et aux États-Unis en avril 2009 et elle s'est propagée rapidement à travers le monde par une transmission entre les êtres humains. Le nouveau type du virus de grippe A [H1N1] est différent de tous ceux qui avaient déjà été isolés [1, 2], à en juger par les premières données publiées en Mai 2009. Il s'agit d'une combinaison dans le désordre de séquences génétiques de lignées provenant des virus des grippes aviaire, humaine et porcine, de l'Amérique du Nord et d'Eurasie. Un haut responsable, virologiste basé à Canberra, en Australie, a déclaré à la presse qu'il pensait que le virus pourrait avoir été créé dans un laboratoire et s’être échappé par accident [3].
    [Show full text]
  • DRAFT Regional Strategic Framework for Vaccine-Preventable Diseases
    WPR/RC71/6 page 7 ANNEX DRAFT Regional Strategic Framework for Vaccine-preventable Diseases and Immunization in the Western Pacific (2021–2030) WPR/RC71/6 page 8 Annex WPR/RC71/6 page 9 Annex Contents Abbreviations 13 Executive summary 15 1. Vaccine-preventable diseases in the Western Pacific Region 17 1.1 Poliomyelitis (polio) 19 1.1.1 Disease 19 1.1.2 Regional epidemiology and context 19 1.1.3 Proposed goal and target for the year of 2030 19 1.1.4 Strategic Directions and related Strategies proposed in Section 2 20 1.2 Measles 20 1.2.1 Disease 20 1.2.2 Regional epidemiology and context 20 1.2.3 Regional goal and target, 21 1.2.4 Strategic Directions and related Strategies proposed in Section 2 21 1.3 Rubella 22 1.3.1 Disease 22 1.3.2 Regional epidemiology and context 22 1.3.3 Regional goal and target 22 1.3.4 Strategic Directions and related Strategies proposed in Section 2 22 1.4 Tetanus 23 1.4.1 Disease 23 1.4.2 Regional epidemiology and context 23 1.4.3 Global goal and target 24 1.4.4 Strategic Directions and related Strategies proposed in Section 2 24 1.5 Hepatitis B 24 1.5.1 Disease 24 1.5.2 Regional epidemiology and context 25 1.5.3 Proposed goal and target for the year of 2030 25 1.5.4 Strategic Directions and related Strategies proposed in Section 2 26 1.6 Diphtheria 26 1.6.1 Disease 26 1.6.2 Regional epidemiology and context 26 1.6.3 Proposed goal and target for the year of 2030 26 1.6.4 Strategic Directions and related Strategies proposed in Section 2 27 1.7 Pertussis 27 1.7.1 Disease 27 1.7.2 Regional epidemiology and context
    [Show full text]
  • Swine Flu Outbreak of 1976 Considered to Be “The Pandemic That Never Was”?
    Remote Learning Packet NB: Please keep all work produced this week. Details regarding how to turn in this work will be forthcoming. April 27 - May 1, 2020 Course: 7 Science ​ Teacher(s): Miss Weisse [email protected] ​ ​ Mrs. Voltin [email protected] ​ Weekly Plan: ​ Monday, April 27 ⬜ Poem ⬜ Review Notes From Last Week ⬜ Read and Take Notes on The Body’s Response to Pathogens ​ ⬜ Make a List of and Define New Words Tuesday, April 28 ⬜ Review Notes from Yesterday ⬜ Read and take notes on White Blood Cells in the Immune System ​ ⬜ Make a List of and Define New Words Wednesday, April 29 ⬜ Poem ⬜ Review Notes and New Words from Monday and Tuesday ⬜ Create an Organization Tree of all the types of WBCs ⬜ Read Articles from pages 1&2 of the Big Picture and Answer Questions ​ ​ Thursday, April 30 ⬜ Review Your Organization Tree of all the types of WBCs ⬜ Read Articles from pages 3&4 of the Big Picture and Answer Questions ​ ​ Friday, May 1 ⬜ Attend Office Hours at 9am! ⬜ Poem ⬜ Read Articles from pages 5&6 of the Big Picture and Answer Questions ​ ​ Statement of Academic Honesty I affirm that the work completed from the packet is I affirm that, to the best of my knowledge, my child mine and that I completed it independently. completed this work independently _______________________________________ _______________________________________ Student Signature Parent Signature Monday, April 27 ➔ Goethe’s The Metamorphosis of Plants Poem! You can find the poem at the end of the packet. ​ ​ ◆ Attempt to recite the poem from the line “The crowded guardian chalice clasps the stem...” ◆ Learn 2-3 more lines by repeating each line to yourself over and over again.
    [Show full text]
  • Recalibrating Vaccination Laws
    RECALIBRATING VACCINATION LAWS EFTHIMIOS PARASIDIS INTRODUCTION ............................................................................................. 2154 I. PLACING THE VACCINE ACT IN HISTORICAL CONTEXT ..................... 2166 A. Manufacturer’s Liability for Vaccine-Related Injuries ............. 2167 1. The Cutter Incident and Vaccine-Induced Polio ................. 2167 2. Cancer and SV40 Contaminated Polio Vaccines ................. 2172 3. Products Liability Claims for Vaccine-Related Injuries ...... 2178 4. Vaccine-Related Injuries and Market Share Liability ......... 2186 B. The 1976 Swine Flu Vaccine: Industry Demands Government Indemnification for Vaccine-Related Injuries ........................... 2192 C. 1980s Public Health Politics: Portraying the FDA as a Bureaucratic Hindrance to Health and Safety .......................... 2200 II. THE VACCINE ACT FRAMEWORK ...................................................... 2208 A. National Vaccine Program: Goals, Funding, and Administration ........................................................................... 2209 B. The National Vaccine Injury Compensation Program .............. 2211 C. The Vaccine Act’s Limits on Tort Claims Against Vaccine Manufacturers ........................................................................... 2219 III. MODERNIZING THE VACCINE ACT ..................................................... 2221 A. Adjusting the Requirements for Adverse Event Reporting and Post-Market Analysis of Vaccine Safety and Efficacy ............... 2222 B. Predicating
    [Show full text]
  • Accelerating Availability of Vaccine Candidates for COVID-19
    POLICY BRIEF SPECIAL EDITION Accelerating Availability of Vaccine Candidates for COVID-19 Eli Dourado March 20, 2020 Without a vaccine for COVID-19, the pandemic will be here for some time. Measures such as social distancing and robust surveillance can control the spread of the disease, but there will always be a risk that a flare-up will take lives, especially those of elderly and immunocompromised individu- als. A return to normalcy depends on the availability of a vaccine, or possibly of several vaccines, as the virus continues to mutate over time. America needs to return to normal as soon as possible, for the sake of the economy if not people’s sanity. Unfortunately, the FDA approval process is not likely to result in a marketable vaccine until sometime next year. To resolve this mismatch in timelines, Congress should create an expedited process to allow patients, via a process of informed consent, to use vaccine candidates that have not yet completed the full FDA approval process. GOOD NEWS AND BAD NEWS ABOUT VACCINES Meeting the need for a vaccine is a “good news, bad news” proposition. The good news is that creating vaccines has never been easier. Thanks to modern science, scientists have ever- advancing tools and more possible approaches than ever before. In addition to traditional whole-pathogen approaches, scientists today can make subunit vaccines as well as state-of- the-art DNA and RNA vaccines. Synthetic biology is being used as a design tool to make these vaccines more effective than ever.1 San Diego–based Inovio Pharmaceuticals claims to have designed a DNA vaccine candidate for COVID-19 only three hours after the publication of the SARS-CoV-2 genome.2 This special edition policy brief is intended to promote effective ideas among key decision-makers in response to the COVID-19 pandemic.
    [Show full text]
  • Focus on Epidemics
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2013 Rezension zu: Georg Dehner, Influenza: A century of science and public health response Honigsbaum, Mark DOI: https://doi.org/10.1093/shm/hkt049 Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-91735 Journal Article Published Version Originally published at: Honigsbaum, Mark (2013). Rezension zu: Georg Dehner, Influenza: A century of science and public health response. Social History of Medicine, 26(4):779-780. DOI: https://doi.org/10.1093/shm/hkt049 Social History of Medicine Vol. 26, No. 4 pp. 779–788 Focus on Epidemics George Dehner, Influenza: A Century of Science and Public Health Response, Pittsburgh, PA: University of Pittsburgh Press, 2012. Pp. vii + 285. $27.95. ISBN 978 0 8229 6189 5. In the past 40 years, technically driven responses to flu pandemics have twice called science and public health into disrepute. The most recent occasion was in 2009 when the unexpected emergence of a quadruple reassortment swine flu virus in Mexico trig- gered contracts for the distribution of billions of dollars worth of antiviral drugs and vac- cines—the political fallout from which, in light of the mild nature of the pandemic, is still the subject of controversy today. The other occasion was in 1976 when the emergence at Fort Dix, New Jersey, of another strain of swine flu prompted the United States Public Health Service to wage an unprecedented nation-wide inoculation campaign. Approved at the highest levels of the Ford government, the programme resulted in the vaccination of 42 million Americans but was soon labelled a costly ‘fiasco’ when people began suffer- ing adverse reactions and the pandemic proved far milder than experts had anticipated.
    [Show full text]
  • Vulnerable Populations and Vaccine Injury Compensation: the Need for Legal Reform
    Case Western Reserve University School of Law Scholarly Commons Faculty Publications 2022 Vulnerable Populations and Vaccine Injury Compensation: The Need for Legal Reform Katharine A. Van Tassel Case Western University School of Law, [email protected] Sharona Hoffman Case Western Reserve University School of Law, [email protected] Follow this and additional works at: https://scholarlycommons.law.case.edu/faculty_publications Part of the Food and Drug Law Commons, and the Health Law and Policy Commons Repository Citation Van Tassel, Katharine A. and Hoffman, Sharona, "Vulnerable Populations and Vaccine Injury Compensation: The Need for Legal Reform" (2022). Faculty Publications. 2092. https://scholarlycommons.law.case.edu/faculty_publications/2092 This Book Chapter is brought to you for free and open access by Case Western Reserve University School of Law Scholarly Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of Case Western Reserve University School of Law Scholarly Commons. Draft - please do not cite without author permission Forthcoming in COVID-19 AND THE LAW: DISRUPTION, IMPACT AND LEGACY (I. Glenn Cohen et al., eds. Cambridge University Press 2022) Vulnerable Populations and Vaccine Injury Compensation: The Need for Legal Reform† Katharine Van Tassel, JD, MPH* and Sharona Hoffman, JD, LLM, SJD** 1. INTRODUCTION Developing a new vaccine takes, on average, ten years.1 In the case of COVID-19, however, the pharmaceutical industry developed vaccines in a matter of months, and three quickly received emergency use authorization.2 As discussed in the chapters by Sachs, Ouellette, Price, and Sherkow, among others in this volume, this record-breaking pace of development raised concerns regarding rare undetected side effects or ones that would manifest only in the long-term.
    [Show full text]